Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:      
Net income $ 4,061,643 $ 2,761,896 $ 3,387,351
Adjustments to reconcile net income to net cash provided by operating activities:      
Impairment of goodwill and purchased intangible assets 239,100 289,474 9,905
Depreciation and amortization 394,088 401,730 415,113
Loss on extinguishment of debt 0 0 13,286
Unrealized foreign exchange (gain) loss and other 14,974 (12,533) (17,825)
Asset impairment charges 0 11,307 0
Disposal of non-controlling interest 0 0 8,270
Stock-based compensation expense 265,011 212,695 171,424
Net gain on sale of assets (161) 0 0
Gain on sale of business 0 0 (29,687)
Deferred income taxes (246,577) (155,228) (298,145)
Settlement of treasury lock agreement 0 415 0
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:      
Accounts receivable (367,897) (80,894) (48,534)
Inventories (155,170) (164,092) (749,047)
Other assets (10,459) (289,509) (121,018)
Accounts payable 33,789 24,976 (144,661)
Deferred system revenue (169,027) 334,136 150,750
Deferred service revenue 100,460 203,106 88,223
Other liabilities (77,871) (228,904) 834,400
Net cash provided by operating activities 4,081,903 3,308,575 3,669,805
Cash flows from investing activities:      
Proceeds from sale of assets 161 5,079 0
Net proceeds from sale of business 0 0 75,358
Business acquisitions, net of cash acquired 0 (3,682) (27,144)
Acquisition of intellectual property (4,950) 0 0
Capital expenditures (335,259) (277,384) (341,591)
Proceeds from capital-related government assistance 6,263 0 0
Purchases of available-for-sale and equity securities (2,772,578) (2,756,987) (1,441,933)
Proceeds from sale of available-for-sale securities 459,620 107,773 124,620
Proceeds from maturity of available-for-sale securities 2,455,815 1,459,864 1,134,182
Purchases of trading securities (118,288) (134,098) (96,611)
Proceeds from sale of trading securities 105,751 121,020 89,528
Proceeds from other investments 984 1,430 1,020
Net cash used in investing activities (202,481) (1,476,985) (482,571)
Cash flows from financing activities:      
Payment of debt issuance costs 0 0 (6,515)
Proceeds from issuance of debt, net of issuance costs 0 735,043 0
Proceeds from revolving credit facility, net of costs 0 0 300,000
Repayment of debt (750,000) 0 (1,087,250)
Common stock repurchases (2,149,946) (1,735,746) (1,311,864)
Payment of dividends to stockholders (904,594) (773,041) (732,556)
Issuance of common stock 151,514 144,934 124,847
Tax withholding payments related to vested and released restricted stock units (132,661) (143,024) (94,806)
Contingent consideration payable and other, net 0 (4,183) (17,850)
Purchase of non-controlling interest 0 0 (4,295)
Net cash used in financing activities (3,785,687) (1,776,017) (2,830,289)
Effect of exchange rate changes on cash and cash equivalents 8,044 (6,309) (13,988)
Net increase in cash and cash equivalents 101,779 49,264 342,957
Cash and cash equivalents at beginning of period 1,977,129 1,927,865 1,584,908
Cash and cash equivalents at end of period 2,078,908 1,977,129 1,927,865
Supplemental cash flow disclosures:      
Income taxes paid, net 886,937 830,835 495,101
Interest paid, net of capitalized interest 292,771 276,597 223,955
Non-cash activities:      
Contingent consideration payable - financing activities 0 (765) (1,878)
Dividends payable - financing activities 8,660 8,043 7,903
Unsettled common stock repurchase - financing activities 5,500 5,500 11,000
Accrued purchases of land, property and equipment - investing activities $ 25,740 $ 13,849 $ 18,445